Geoffrey Ling Net Worth

The estimated Net Worth of Geoffrey M.D. Ling is at least $1.53 Thousand dollars as of 25 February 2020. Geoffrey Ling owns over 3,000 units of Catalyst Biosciences Inc stock worth over $1,530 and over the last 5 years he sold CBIO stock worth over $0. In addition, he makes $0 as Independent Director at Catalyst Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Geoffrey Ling CBIO stock SEC Form 4 insiders trading

Geoffrey has made over 1 trades of the Catalyst Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of CBIO stock worth $18,690 on 25 February 2020.

The largest trade he's ever made was buying 3,000 units of Catalyst Biosciences Inc stock on 25 February 2020 worth over $18,690. On average, Geoffrey trades about 273 units every 0 days since 2020. As of 25 February 2020 he still owns at least 3,000 units of Catalyst Biosciences Inc stock.

You can see the complete history of Geoffrey Ling stock trades at the bottom of the page.

Geoffrey Ling biography

Dr. Geoffrey Ling M.D. Ph.D. serves as Independent Director of the Company. Dr. Ling has been Professor of Neurology and Attending Neuro Critical Care Physician at Johns Hopkins Medical Institutions since 2000 and the Emeritus Professor of Neurology, Uniformed Services University of the Health Science since 2017. He has also been Vice-Chair of Research in the Department of Clinical Neurosciences at Inova Fairfax Medical Center, Fairfax, Virginia since 2017. In September 2016, he co-founded Predigen, Inc., a molecular diagnostics company, and since January 2016, he has served as the Chief Executive Officer of On Demand Pharmaceuticals, Inc., a company that he founded in 2016. Dr. Ling served as the Director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2004 to 2015. Dr. Ling received a B.S. in Biology and History from Washington University, a Ph.D. in Pharmacology from Cornell University - Graduate School of Medical Sciences and an M.D. from Georgetown University School of Medicine.

How old is Geoffrey Ling?

Geoffrey Ling is 63, he's been the Independent Director of Catalyst Biosciences Inc since 2020. There are 5 older and 5 younger executives at Catalyst Biosciences Inc. The oldest executive at Catalyst Biosciences Inc is Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D., 67, who is the Consultant.

What's Geoffrey Ling's mailing address?

Geoffrey's mailing address filed with the SEC is C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BLVD. SUITE 710, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Catalyst Biosciences Inc

Over the last 9 years, insiders at Catalyst Biosciences Inc have traded over $2,614,728 worth of Catalyst Biosciences Inc stock and bought 81,771 units worth $199,380 . The most active insiders traders include Jeff Himawan, James E Deerfield Mgmt L.P...., and Augustine Lawlor. On average, Catalyst Biosciences Inc executives and independent directors trade stock every 62 days with the average trade being worth of $3,315. The most recent stock trade was executed by Nassim Usman on 9 August 2022, trading 3,250 units of CBIO stock currently worth $1,528.

What does Catalyst Biosciences Inc do?

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

Complete history of Geoffrey Ling stock trades at Catalyst Biosciences Inc

Catalyst Biosciences Inc executives and stock owners

Catalyst Biosciences Inc executives and other stock owners filed with the SEC include:

• Nassim Usman,
  President, Chief Executive Officer, Director
• Dr. Nassim Usman Ph.D.,
  Pres, CEO & Director
• Howard Levy,
  Chief Medical Officer
• Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
  Consultant
• Augustine Lawlor,
  Independent Chairman of the Board
• Errol De Souza,
  Independent Director
• Andrea Hunt,
  Independent Director
• Edward Williams,
  Independent Director
• Ana Kapor,
  IR Contact Officer
• Sharon Tetlow,
  Independent Director
• Geoffrey Ling,
  Independent Director
• Charles Democko,
  Senior Vice President - Regulatory Affairs
• Clinton Musil,
  Chief Financial Officer
• Dr. Tom Knudsen D.V.M., Ph.D.,
  Sr. VP of Corp. Devel.
• Dr. Grant Blouse M.Sc., Ph.D.,
  Chief Scientific Officer
• Seline Miller CPA,
  Sr. VP of Fin., Interim Chief Financial & Principal Accounting Officer
• John P Richard,
  Director
• Stephen A Hill,
  Director
• Edwin Madison,
  Chief Scientific Officer
• Fletcher Payne,
  Chief Financial Officer
• Harold E Selick,
  Director
• Group Ltd.Gni Hong Kong Ltd...,
  
• Seline E. Miller,
  SVP Finance; Interim CFO & PAO
• James E Deerfield Mgmt L.P....,
  
• Eddie Williams,
  Director
• Jeff Himawan,
  Director
• Veronica Cai,
  Controller
• Grant E. Blouse,
  Chief Scientific Officer
• Jeanne Y Jew,
  Director
• Hong Kong Ltd Gni,